Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CADME
2012-005486-13Phase 2Completed
- Sponsor
- National Eye Institute
- Start
- Feb 2013
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab, bevacizumab in diabetic macular edema (DME), sponsored by National Eye Institute. Started Feb 2013; status: completed.
02
Drugs
ranibizumabbevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2012-005486-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005486-13.